Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2013

Jan 4, 2013

30870_dirs_2013-01-04_d82ac48c-5d6b-4296-8a26-a1e00bfcec50.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2013-01-02

Reporting Person: GAGE L PATRICK (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-01-02 Non-Qualified Stock Option (right to buy) $0.6702 A 223813 Acquired 2023-01-02 Common Stock (223813) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Option (right to buy) $0.91 2022-05-22 Common Stock (25000) 25000 Direct
Non-Qualified Stock Option (right to buy) $0.98 2022-01-03 Common Stock (102040) 102040 Direct
Non-Qualified Stock Option (right to buy) $1.44 2021-05-18 Common Stock (20000) 20000 Direct
Non-Qualified Stock Option (right to buy) $2.16 2021-01-03 Common Stock (46296) 46296 Direct
Non-Qualified Stock Option (right to buy) $2.81 2020-05-20 Common Stock (20000) 20000 Direct
Non-Qualified Stock Option (right to buy) $3.33 2019-11-05 Common Stock (30000) 30000 Direct

Footnotes

F1: This option shall vest and become exercisable as to 223,813 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2014.

F2: This option was issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of an annual retainer of $60,000.

F3: This option shall vest and become exercisable as to 25,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 22, 2013.

F4: This option shall vest and become exercisable as to 102,040 shares divided into equal monthly installments such that the option shall be 100% vested on January 3, 2013.

F5: This option shall vest and become exercisable as to 20,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 18, 2012.

F6: This option shall vest and become exercisable as to 46,296 shares divided into equal monthly installments such that the option shall be 100% vested on January 3, 2012.

F7: This option shall vest and become exercisable as to 20,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 20, 2011.

F8: This option shall vest and become exercisable as to 833 shares on 12/05/09 and the balance of 29,167 divided into equal monthly installments thereafter such that the option shall be 100% vested on 11/05/12.